Literature DB >> 25206050

Focal delivery of AAV2/1-transgenes into the rat brain by localized ultrasound-induced BBB Opening.

Angelika Alonso1, Eileen Reinz2, Barbara Leuchs2, Jürgen Kleinschmidt2, Marc Fatar1, Bart Geers3, Ine Lentacker3, Michael G Hennerici1, Stefaan C de Smedt3, Stephen Meairs1.   

Abstract

Entities:  

Year:  2014        PMID: 25206050      PMCID: PMC4117153          DOI: 10.5214/ans.0972.7531.210107

Source DB:  PubMed          Journal:  Ann Neurosci        ISSN: 0972-7531


× No keyword cloud information.

Background

Blood brain barrier (BBB) is one of the major components of central nervous system (CNS) which prevents all kinds of external molecules to infest CNS.[1] However this protection also prevents gene and targeted drug delivery to CNS. The tight junctions of BBB pose as an impermeable wall for components to penetrate within the BBB.[2] Recently an upcoming approach of utilizing Ultrasound with ultrasound contrast components is of intrest to researchers as it allows the penetration of these components without damaging neuronal cell. Using the above technique till now antibodies or plasmid DNA has been successfully delivered into rodents.[3]

Study Design

The vector plasmid encoding for AAV2 terminal repeat elements and the transgene nlsLAcZ (nuclear localization signal; β-galactosidase) driven by a CMV promoter was created. For opening of BBB 500 KHZ transducer was used. It was positioned stereotacticaly over the wistar rat and one hemisphere was isonated. Transducer was run by wave form generator and amplifier. To validate BBB opening the rat had to undergo MRI scan of brain. Gulodinum a chemical which do not pass the intact BBB in histochemical sections was found to be located in transfected cells of CNS. Immunohistochemistery and RTPCR quantification were done to analyse the transfection of vector plasmid into the rat brain.

Implications

Authors describe the targeted delivery of AAV into BBB by ultrasound. It opens up new paths and possibilities to treat disorders linked to CNS. However further studies on animal models are required to validate the technique having immense potential in clinical therapy.
  3 in total

1.  Neurons but not glial cells overexpress ubiquitin in the rat brain following focused ultrasound-induced opening of the blood-brain barrier.

Authors:  A Alonso; E Reinz; M Fatar; J Jenne; M G Hennerici; S Meairs
Journal:  Neuroscience       Date:  2010-04-21       Impact factor: 3.590

Review 2.  The blood-brain barrier: bottleneck in brain drug development.

Authors:  William M Pardridge
Journal:  NeuroRx       Date:  2005-01

Review 3.  Ultrasound, microbubbles and the blood-brain barrier.

Authors:  Stephen Meairs; Angelika Alonso
Journal:  Prog Biophys Mol Biol       Date:  2006-08-04       Impact factor: 3.667

  3 in total
  4 in total

1.  Real-Time Passive Acoustic Mapping Using Sparse Matrix Multiplication.

Authors:  Hermes A S Kamimura; Shih-Ying Wu; Julien Grondin; Robin Ji; Christian Aurup; Wenlan Zheng; Marc Heidmann; Antonios N Pouliopoulos; Elisa E Konofagou
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2020-12-23       Impact factor: 2.725

2.  Contrast-Free Detection of Focused Ultrasound-Induced Blood-Brain Barrier Opening Using Diffusion Tensor Imaging.

Authors:  Maria Eleni Karakatsani; Antonios N Pouliopoulos; Michael Liu; Sachin R Jambawalikar; Elisa E Konofagou
Journal:  IEEE Trans Biomed Eng       Date:  2021-07-16       Impact factor: 4.756

Review 3.  Focused Ultrasound for Essential Tremor: Review of the Evidence and Discussion of Current Hurdles.

Authors:  Mohammad Rohani; Alfonso Fasano
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-05-05

4.  Strategy to enhance transgene expression in proximity of amyloid plaques in a mouse model of Alzheimer's disease.

Authors:  Danielle Weber-Adrian; Rikke Hahn Kofoed; Josephine Wing Yee Chan; Joseph Silburt; Zeinab Noroozian; Sebastian Kügler; Kullervo Hynynen; Isabelle Aubert
Journal:  Theranostics       Date:  2019-10-18       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.